Australia, Feb. 20 -- Ionis Pharmaceuticals Inc., owns the trademark (2590322) for 'DAWNZEER' till Sept. 26, 2035.
Status: registered:
Registered/protected
Classes: 5 [Pharmaceutical preparations and substances for the treatment of edema, namely, hereditary angioedema; pharmaceutical products and preparations in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders.], 44 [Medical services; medical information services; providing medical and healthcare information for healthcare professionals, caregivers, patients, and providers in the fields of autosomal dominant, autosomal recessive, genetic, edema...